首页> 美国卫生研究院文献>Dong wu xue yan jiu = Zoological Research >Purification and characterization of a novel anti-coagulant from the leech Hirudinaria manillensis
【2h】

Purification and characterization of a novel anti-coagulant from the leech Hirudinaria manillensis

机译:一种来自水anti的新型抗凝剂的纯化与表征

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Protease inhibitors have been reported rarely from the leech Hirudinaria manillensis. In this study, we purified a novel protease inhibitor (bdellin-HM-2) with anticoagulant properties from H. manillensis. With a molecular weight of 1.4x104, bdellin-HM-2 was also characterized with three intra-molecular disulfide bridges at the N-terminus and multiple HHXDD and HXDD motifs at the C-terminus. cDNA cloning revealed that the putative nucleotide-encoding protein of bdellin-HM-2 contained 132 amino acids and was encoded by a 399 bp open reading frame (ORF). Sequence alignment showed that bdellin-HM-2 shared similarity with the “non-classical” Kazal-type serine protease inhibitors, but had no inhibitory effect on trypsin, elastase, chymotrypsin, kallikrein, factor XIIa (FXIIa), factor XIa (FXIa), factor Xa (FXa), thrombin, or plasmin. Bdellin-HM-2 showed anticoagulant effects by prolonging the activated partial thromboplastin time (aPTT), indicating a role in enabling H. manillensis to obtain a blood meal from its host. Our results suggest that bdellin-HM-2 may play a crucial role in blood-sucking in this leech species and may be a potential candidate for the development of clinical anti-thrombotic drugs.
机译:很少有来自水Hi水ill的蛋白酶抑制剂的报道。在这项研究中,我们从山茱。中纯化了一种具有抗凝特性的新型蛋白酶抑制剂(bdellin-HM-2)。 bdellin-HM-2的分子量为1.4x10 4 ,在N端具有三个分子内二硫键,在C端具有多个HHXDD和HXDD基序。 cDNA克隆显示,推定的bdellin-HM-2核苷酸编码蛋白含有132个氨基酸,并由一个399 bp的开放阅读框(ORF)编码。序列比对显示bdellin-HM-2与“非经典” Kazal型丝氨酸蛋白酶抑制剂具有相似性,但对胰蛋白酶,弹性蛋白酶,胰凝乳蛋白酶,激肽释放酶,XIIa因子(FXIIa),XIa因子(FXIa)没有抑制作用,因子Xa(FXa),凝血酶或纤溶酶。 Bdellin-HM-2通过延长活化的部分凝血活酶时间(aPTT)表现出抗凝作用,表明在使曼氏嗜血杆菌从其宿主中获得血粉的作用。我们的结果表明,bdellin-HM-2可能在该水ech物种的吸血中起关键作用,并且可能是临床抗血栓形成药物开发的潜在候选者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号